# Oral Intake of Mg in Controlled Asthmatic Patients

> **NCT06721247** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Zagazig University** · enrollment: 166 (estimated)

## Conditions studied

- Bronchial Asthma

## Interventions

- **DRUG:** Magnesium
- **DRUG:** ICS+LABA

## Key facts

- **NCT ID:** NCT06721247
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-02
- **Primary completion:** 2025-11-02
- **Final completion:** 2025-11-02
- **Target enrollment:** 166 (ESTIMATED)
- **Last updated:** 2025-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06721247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06721247, "Oral Intake of Mg in Controlled Asthmatic Patients". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT06721247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*